Transdermal and Transmucosal Delivery of Therapeutics 2nd Edition

D&MD's Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition market analysis report estimates the transdermal/transmucosal drug delivery market is poised for growth through 2010.

Delivering drugs non-invasively through the skin, and particularly through the mucosa in the oral cavity or nose, has grown from a specialized application field to a formulation option that is not only convenient for the patient but also combines sustained or flash delivery with improved metabolic profile. While transdermal and transmucosal drug delivery had mainly focused on smoking cessation and cancer pain a few years ago, the therapeutic scope has since dramatically expanded to include contraception, sexual dysfunction, alcohol abuse, attention deficit disorder, and Parkinson's disease, among others. In addition, new chemical entities are now being specifically tailored for this route of administration as a competitive marketing strategy.

Scope

Transdermal and transmucosal delivery is much more than just a niche market within drug delivery.

This report highlights the technologies and drugs currently available for transdermal, buccal and intranasal routes of administration as well as an analysis of the potential market for drug delivery. A summary of the intellectual property landscape in this area, profiles of companies invested in transdermal and transmucosal drug delivery and interviews with key industry players round out this comprehensive report.

Market Opportunities

Develop new long-lasting transdermal patches capable of being applied to the skin while administrating the correct dosage of the prescribed drug, thus increasing patient compliance and convenience.

Create transdermal or transmucosal means of delivering low but efficacious drug concentrations to the target site in order to reduce the potential for product addiction.

Promote products capable of improving patient quality of life and long-term outcomes by controlling plasma drug concentrations.

Salvage drugs with poor pharmacokinetic, pharmacological or toxicity properties when formulated as enterics.

Speed CNS active drugs to target through nasal mucosa.

Key Reasons to Buy

Pinpoint the full market potential of transdermal and transmucosal drug delivery systems with an examination of the projected impact through 2010.

Understand the basic concepts behind transdermal and transmucosal drug delivery through a detailed review of the different mucosal sites, transdermal delivery options, and the economic considerations for both.

Compare and contrast existing transdermal and transmucosal drug delivery systems through a detailed overview of the different devices and formulations available.

Gain insight into the markets for transdermal and transmucosal drug delivery through a comprehensive review of the wide-ranging traditional and emerging therapeutic applications.

Discover the current intellectual property landscape via an in-depth review of patents covering transdermal and transmucosal drug delivery.

Examine product pipelines, partnerships & alliances, business strategies, technologies, as well as other information from companies within the transdermal and transmucosal drug delivery field.

Published: 15 February 2007

Pages: 300

PDF Format
Table of Contents

Price